Sponsored By
Abbvie to acquire ovarian cancer drug company
Pharma & Medical Products
Abbvie to Acquire ImmunoGen for $10.1 BillionAbbvie to Acquire ImmunoGen for $10.1 Billion
ImmunoGen's oncology portfolio has the potential to help drive long-term revenue growth for AbbVie's oncology franchise.
byStaff
Sign up for the Powder & Bulk Solids Weekly newsletter.